Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › VI › ST THOMAS › VI GOVERNMENT HOSPITAL AND HEALTH FACILITIES CORP

VI GOVERNMENT HOSPITAL AND HEALTH FACILITIES CORP

NPI: 1487699047 · ST THOMAS, VI 00802 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/18/2006

$23.63M
Total Medicaid Paid
425,572
Total Claims
313,173
Beneficiaries
215
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialCOMISSIONG, TINA (CEO)
NPI Enumeration Date06/18/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 40,426 $2.93M
2019 64,980 $3.80M
2020 61,411 $3.22M
2021 68,609 $3.84M
2022 70,704 $4.14M
2023 70,149 $3.58M
2024 49,293 $2.11M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
36415 Collection of venous blood by venipuncture 27,390 23,637 $6.70M
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 12,794 1,153 $2.38M
99281 Emergency department visit for the evaluation and management, self-limited or minor 7,375 6,223 $1.47M
99282 Emergency department visit for the evaluation and management, low to moderate severity 28,670 19,585 $1.42M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,462 4,027 $867K
81003 15,688 14,175 $720K
J0882 Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) 5,620 1,584 $704K
Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml 2,534 2,381 $697K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,793 1,260 $605K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 5,611 4,659 $577K
77067 Screening mammography, bilateral, including computer-aided detection 1,818 1,741 $555K
90999 Unlisted dialysis procedure, inpatient or outpatient 23,669 1,856 $549K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,322 2,987 $522K
80053 Comprehensive metabolic panel 14,489 12,887 $381K
J2501 Injection, paricalcitol, 1 mcg 16,933 1,400 $358K
71046 Radiologic examination, chest; 2 views 3,308 3,060 $351K
J0606 Injection, etelcalcetide, 0.1 mg 2,254 213 $292K
87070 2,325 2,133 $279K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,148 1,057 $274K
70450 Computed tomography, head or brain; without contrast material 2,298 2,116 $248K
J1644 Injection, heparin sodium, per 1000 units 3,180 496 $246K
99283 Emergency department visit for the evaluation and management, moderate severity 22,094 15,833 $227K
88313 2,129 1,838 $208K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 790 760 $199K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 551 508 $164K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 22,326 19,235 $161K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,040 935 $161K
84703 2,955 2,662 $158K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 533 526 $156K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,725 2,071 $139K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,239 3,031 $133K
G0378 Hospital observation service, per hour 4,162 2,196 $130K
71045 Radiologic examination, chest; single view 2,157 1,924 $102K
88142 1,518 1,424 $84K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,326 1,316 $82K
99284 Emergency department visit for the evaluation and management, high severity 7,218 5,742 $80K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,796 1,689 $71K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,194 3,737 $63K
82948 1,062 909 $54K
87088 5,741 5,153 $52K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,834 2,592 $41K
99001 8,661 7,971 $38K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,645 3,233 $38K
74176 Computed tomography, abdomen and pelvis; without contrast material 279 264 $35K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 551 518 $33K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,516 1,164 $29K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,911 4,355 $28K
87177 1,724 1,696 $27K
76801 100 94 $27K
73030 148 132 $24K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,038 1,743 $24K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 75 60 $24K
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 82 75 $23K
80061 Lipid panel 5,564 5,294 $21K
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,176 4,361 $21K
80048 Basic metabolic panel (calcium, ionized) 3,340 3,053 $20K
96376 246 230 $20K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 49 49 $19K
83036 Hemoglobin; glycosylated (A1C) 4,560 4,292 $18K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 996 805 $17K
84443 Thyroid stimulating hormone (TSH) 4,586 4,269 $16K
90656 101 92 $16K
29581 487 130 $16K
72100 93 88 $14K
93000 426 395 $14K
J1170 Injection, hydromorphone, up to 4 mg 826 554 $14K
96361 Intravenous infusion, hydration; each additional hour 2,688 2,388 $13K
85014 759 681 $13K
73630 106 87 $13K
86850 1,199 1,022 $13K
88141 215 191 $12K
96375 Therapeutic injection; each additional sequential IV push 3,837 3,410 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 501 426 $12K
82485 2,641 2,451 $11K
94664 472 390 $10K
82310 1,150 1,107 $10K
82272 281 276 $9K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 2,857 2,498 $9K
87807 543 493 $9K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 44 42 $9K
87077 3,119 2,857 $9K
82553 1,046 972 $9K
73562 65 54 $9K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 3,750 1,114 $9K
84484 2,609 2,334 $8K
84702 932 770 $8K
73610 32 27 $8K
88108 237 236 $8K
J0735 Injection, clonidine hydrochloride, 1 mg 64 44 $7K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 379 319 $7K
J2270 Injection, morphine sulfate, up to 10 mg 1,225 1,039 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 273 250 $6K
90837 Psychotherapy, 53 minutes with patient 34 12 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,331 1,174 $5K
G0008 Administration of influenza virus vaccine 50 50 $5K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 14 14 $5K
72125 Computed tomography, cervical spine; without contrast material 41 40 $5K
85610 1,615 1,448 $5K
87481 36 36 $5K
90792 Psychiatric diagnostic evaluation with medical services 28 17 $5K
J0690 Injection, cefazolin sodium, 500 mg 1,537 1,218 $4K
82803 591 538 $4K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 14 13 $4K
76819 Fetal biophysical profile; without non-stress testing 34 15 $4K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 680 636 $4K
87040 264 241 $4K
86703 1,338 1,271 $3K
84153 770 708 $3K
82465 1,717 1,684 $3K
84550 1,665 1,498 $3K
J7120 Ringers lactate infusion, up to 1000 cc 279 221 $3K
97602 155 38 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,917 1,684 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 100 25 $3K
83880 607 562 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg 228 196 $3K
J2175 Injection, meperidine hydrochloride, per 100 mg 45 40 $3K
87186 2,556 2,357 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material 102 94 $3K
84439 1,606 1,479 $3K
86900 1,538 1,307 $3K
90714 245 242 $2K
83550 430 367 $2K
J2060 Injection, lorazepam, 2 mg 133 121 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 134 100 $2K
J7030 Infusion, normal saline solution , 1000 cc 42 37 $2K
83735 1,260 1,133 $2K
86592 1,520 1,478 $2K
83690 1,798 1,638 $2K
J2704 Injection, propofol, 10 mg 1,047 777 $2K
73130 12 12 $2K
84132 2,716 2,518 $2K
J7510 Prednisolone oral, per 5 mg 21 12 $2K
71275 Computed tomographic angiography, chest, with contrast material 13 13 $1K
85651 1,508 1,410 $1K
85379 256 244 $1K
82270 168 149 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,233 3,030 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 79 73 $1K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 250 190 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 50 12 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 2,316 2,002 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 84 52 $1K
82570 331 316 $918.50
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 50 50 $901.36
93017 14 13 $764.00
V2632 Posterior chamber intraocular lens 16 16 $726.00
84446 236 210 $678.38
83605 1,452 1,324 $665.06
80069 65 52 $516.19
96367 166 157 $492.78
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 15 14 $466.80
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 448 442 $450.68
J1094 Injection, dexamethasone acetate, 1 mg 1,589 1,332 $409.29
81015 3,191 2,737 $408.29
80076 42 42 $402.01
J1756 Injection, iron sucrose, 1 mg 36 15 $402.01
83021 973 957 $402.01
76000 30 30 $385.80
86901 992 824 $380.02
84295 2,643 2,453 $360.38
82550 867 842 $324.89
85730 1,172 1,087 $311.57
83615 797 778 $290.20
86140 541 499 $284.78
82565 2,088 1,979 $205.87
83874 1,046 972 $158.14
82728 787 709 $71.39
87563 51 51 $43.60
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 84 83 $43.06
86141 108 100 $42.00
84100 752 730 $40.83
82607 101 87 $37.59
82746 101 87 $37.59
J2550 Injection, promethazine hcl, up to 50 mg 79 66 $26.00
84481 30 25 $23.60
85018 58 53 $22.09
84479 72 66 $18.35
83921 13 12 $17.91
82150 13 12 $17.73
82043 37 26 $13.15
86803 46 37 $12.80
94760 13 13 $12.19
82947 2,639 2,449 $5.39
J2765 Injection, metoclopramide hcl, up to 10 mg 16 13 $5.00
87340 369 349 $4.80
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 99 57 $4.15
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 84 55 $4.00
83655 1,202 1,178 $0.00
S0028 Injection, famotidine, 20 mg 100 84 $0.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 21 16 $0.00
81513 37 37 $0.00
87535 52 52 $0.00
86336 20 20 $0.00
84156 14 14 $0.00
84165 12 12 $0.00
86235 39 39 $0.00
83540 24 24 $0.00
S5010 5% dextrose and 0.45% normal saline, 1000 ml 16 14 $0.00
84155 12 12 $0.00
84478 685 669 $0.00
86701 50 50 $0.00
85660 972 956 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 170 155 $0.00
85027 21 20 $0.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 28 12 $0.00
86762 98 96 $0.00
86225 43 43 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 29 28 $0.00
82677 19 19 $0.00
82105 19 19 $0.00
88304 13 12 $0.00
87184 15 13 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 14 13 $0.00
87522 Neg quan hep c or qual rna 13 13 $0.00